Surriga, Oliver <br/><br/>
Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2013 
 - 2817-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-13-0499  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Crizotinib<br/>Disease Models, Animal<br/>Gene Expression<br/>Gene Knockdown Techniques<br/>Hepatocyte Growth Factor--biosynthesis<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Mice<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Pyrazoles--administration & dosage<br/>Pyridines--administration & dosage<br/>RNA, Small Interfering--genetics<br/>Tumor Burden--drug effects<br/>Uveal Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays<br/>Uveal Melanoma